Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glycocalyx is a dense, carbohydrate-rich layer that coats the apical surface of gastrointestinal epithelial cells. It consists primarily of glycoproteins, glycolipids, proteoglycans, and mucins that project from the plasma membrane into the intestinal lumen. This structure forms a meshwork approximately 0.3 μm thick and plays critical roles in digestion, barrier function, and host-microbe interactions. Disruption or alteration in glycocalyx composition is linked to increased susceptibility to gastrointestinal disorders including inflammatory bowel disease (IBD), Crohn’s disease (CD), or colitis.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycocalyx at the Gastrointestinal Cell Surface (N/A).